Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Dow
Mallinckrodt
Moodys
McKinsey

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020833

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 020833 describes FLOVENT DISKUS 50, which is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. Additional details are available on the FLOVENT DISKUS 50 profile page.

The generic ingredient in FLOVENT DISKUS 50 is fluticasone propionate. There are twenty-nine drug master file entries for this compound. Eighty-one suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
Summary for 020833
Tradename:FLOVENT DISKUS 50
Applicant:Glaxo Grp Ltd
Ingredient:fluticasone propionate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020833
Suppliers and Packaging for NDA: 020833
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLOVENT DISKUS 100 fluticasone propionate POWDER;INHALATION 020833 NDA GlaxoSmithKline LLC 0173-0600 0173-0600-02 1 INHALER in 1 CARTON (0173-0600-02) > 60 POWDER, METERED in 1 INHALER
FLOVENT DISKUS 100 fluticasone propionate POWDER;INHALATION 020833 NDA GlaxoSmithKline LLC 0173-0601 0173-0601-00 1 INHALER in 1 CARTON (0173-0601-00) > 28 POWDER, METERED in 1 INHALER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.05MG/INH
Approval Date:Sep 29, 2000TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.1MG/INH
Approval Date:Sep 29, 2000TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.25MG/INH
Approval Date:Sep 29, 2000TE:RLD:Yes

Expired US Patents for NDA 020833

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxo Grp Ltd FLOVENT DISKUS 250 fluticasone propionate POWDER;INHALATION 020833-003 Sep 29, 2000   Start Trial   Start Trial
Glaxo Grp Ltd FLOVENT DISKUS 250 fluticasone propionate POWDER;INHALATION 020833-003 Sep 29, 2000   Start Trial   Start Trial
Glaxo Grp Ltd FLOVENT DISKUS 100 fluticasone propionate POWDER;INHALATION 020833-002 Sep 29, 2000   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Boehringer Ingelheim
Medtronic
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.